The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Marine Biotechnology
Aquaculture
Fisheries
VIRGIN salmon - a sustainable solution for coexistence but not mixing of farmed and wild salmon strains
National Programme
National
Anna Troedsson-Wargelius
NA
IMR - Institute of Marine Research (Norway)
NA
2017
2021
€ 810,526
https://prosjektbanken.forskningsradet.no/en/project/FORISS/267478?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=90&ProgAkt.3=BIOTEK2021-Bioteknologi%20for%20verdiskaping&source=FORISS&projectId=271368
Salmon farming is a key industry in Norway, with first hand value above forty billion NOK per year.The salmon industry is a major driving force for biotechnological applications in the marine sector. One major bottleneck in the salmon farming industry is the genetic impact of escaped farmed salmon on wild populations. To solve this problem, the industry can use sterile salmon in production. Sterile salmon are currently produced by triploidisation of salmon embryos. However, triploid salmon are generally more sensitive to suboptimal rearing environments making them prone to deformities. Therefore the Norwegian Food authorities has in some cases been very Critical to this Production Method. As previously shown by our research group, we can make sterile salmon by preventing formation of germ cells. The VIRGIN salmon idea presented here describes our strategy to rescue broodstock fish from losing their germ cells, while ensuring that these broodstock fish produce 100% sterile offspring. This approach solves the problems with genetic introgression, precocious maturation and ensures a stable production of genetic breeds, and thus represents a significant commercial potential. Since these sterile salmon are produced by targeted editing of their genome, they are currently considered a genetically modified organism (GMO). and are thus banned from food production in Norway. In some countries like Sweeden, the definition of GMO has been revised and fish subject to the type of Genetic editing described in this Project would not be considered GMO. The commercial potential in developing a new method for production of sterile salmon is large as it will solve some of the major challenges in salmon farming. Breeding companies are demanding improved methods for production of sterile salmon and are potential customers. Licensing or sales of IPR are realistic business models. The Norwegian salmon farming industry may have annual savings for more than 1 billion NOK.
Germ cell-free animals; Genetic; Escapes; Salmon; Fish; Environmental impact;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */